参芍口服液对冠状动脉介入治疗术后再狭窄的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

河北省科技计划项目(11276103D-90)


The Effect of Shenshao Oral Lotion to Restenosis after Percutaneous Coronary Intervention
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 观察参芍口服液对PCI术后患者血脂、血液流变学以及术后支架内再狭窄的影响。方法 PCI术后患者1 023例,随机分为常规服药组514例和参芍口服液组509例,常规服药组采用西医常规治疗,参芍口服液组在常规治疗基础上加用参芍口服液,对两组患者随访12个月。结果 参芍口服液组患者血清TC、TG和LDLC均有下降,与用药前相比差异有统计学意义(P<0.05),LDLC与常规服药组同期相比差异有统计学意义(P<0.05)。两组患者血液流变学指标均有降低,且参芍口服液组各指标值较同期常规服药组降低更显著,差异均有统计学意义(均P<0.05)。支架植入血管段管腔内径净获得、管腔面积净获得均大于常规服药组(P<0.05)。结论 参芍口服液对PCI术后再狭窄的预防有一定作用。

    Abstract:

    Aim To observe the effect of Shenshao oral lotion to blood lipid,hemorrheology,and stent restenosis in patients after percutaneous coronary coronary intervention (PCI). Methods 1 023 patients with coronary heart disease were recruited into our study. Patients were randomly divided into two groups: conventional therapy group and ShenShao oral lotion taking group. Results The level of LDLC in patients of Shenshao oral lotion group decreased lower than that in conventional group in the same period. The indices of blood rheology in patients of Shenshao oral lotion were decreased lower than that in conventional therapy group. The late stage inner loss of the ShenShao oral lotion group was less than the conventional medicine group (P<0.05). Conclusion Shenshao oral lotion could effectively prevent restenosis after PCI.

    参考文献
    相似文献
    引证文献
引用本文

张 琦,刘晓堃,李映雪,薛忠文,刘晓明,刘长青,岳博成,陈 超,尚小明.参芍口服液对冠状动脉介入治疗术后再狭窄的影响[J].中国动脉硬化杂志,2013,21(10):903~906.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2013-05-13
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: